SVB CAPITAL MANAGEMENT LLC
Q3 2024 Form 13-F

MENLO PARK, DELAWARE
CIK 0002011811 · CRD 326747 · SEC-registered investment adviser
$110.7M Reported Value Total

PINEGROVE VENTURE PARTNERS, LLC reports 64 total accounts under management (AUM). There are 64 discretionary accounts valued at $12,171,281,084, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
77 funds · $23.0B gross asset value
Private Equity Fund: $20.7B · Other: $1.8B · Venture Capital Fund: $505.7M
Source: Form ADV filed 2026-06-01
Reported value
$110.7M
Quarter over quarter
0.0%
Holdings
7
Top-10 concentration
100.0%

Filing Structure

Holdings reported by

Key People

Form ADV owners & control persons
Jillana Jodell Downing
CHIEF COMPLIANCE OFFICER
James Ellis Ellison
MANAGING PARTNER
Aaron Garth Gershenberg
CEO

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2024 13F record

Q3 2024 13F filing summary

Q3 2024 Form 13F portfolio summary
Period of report September 30, 2024
Filed November 13, 2024
Form 13F-HR
Reported value $110.7M
Positions 7
Change in reported value First reported quarter
Top-10 concentration 100.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 6, 2026
8 $339.8M
Q2 2026 13F
Filed Aug 10, 2026
6 $7.4M
Q1 2026 13F
Filed May 13, 2026
5 $2.1M
Q4 2025 13F
Filed Feb 17, 2026
5 $2.8M
Q3 2025 13F
Filed Nov 3, 2025
9 $31.7M
Q2 2025 13F
Filed Aug 13, 2025
11 $62.8M
Q1 2025 13F
Filed May 13, 2025
9 $33.9M
Q4 2024 13F
Filed Feb 7, 2025
9 $69.4M
Q3 2024 13F
Filed Nov 13, 2024
7 $110.7M

Top 7 holdings · Q3 2024

Largest Q3 2024 13F positions by reported value
# Holding Reported value % of portfolio
1 COIN COINBASE GLOBAL INC $73.6M 66.52%
2 ROOT ROOT INC $29.6M 26.72%
3 OKTA OKTA INC $4.0M 3.57%
4 AXSM AXSOME THERAPEUTICS INC $3.0M 2.75%
5 PL PLANET LABS PBC $383.8K 0.35%
6 SKLZ SKILLZ INC $78.4K 0.07%
7 PACB PACIFIC BIOSCIENCES CALIF IN $35.0K 0.03%

Values as reported on the Q3 2024 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings